TABLE 5.
BAI | BDI | |
|
||
B (95% CI) | B (95% CI) | |
Time (reference = Screening) | ||
First visit | −7.17 (−11.22; −3.12) | −8.70 (−12.08; −5.32) |
Second visit | −13.25 (−17.73; −8.77) | −14.25 (−17.91; −10.59) |
Third visit | −14.46 (−19.27; −9.65) | −14.62 (−18.54; −10.7) |
Follow-up (6 months) | −13.03 (−19.01; −7.06) | −13.66 (−18.51; −8.81) |
Group (reference = Omega-3) | ||
Placebo | 1.85 (−2.6; 6.3) | −1.22 (−5.24; 2.79) |
Time × Group | ||
First visit | −5.37 (−11.45; 0.7) | −0.08 (−5.06; 4.9) |
Second visit | −0.53 (−7.24; 6.18) | 2.98 (−2.42; 8.38) |
Third visit | 0.5 (−6.42; 7.43) | 0.97 (−4.73; 6.66) |
Follow-up (6 months) | −2.42 (−10.78; 5.93) | 0.54 (−6.31; 7.4) |
Mixed linear models.
In all models, time, group and interaction were included as fixed effects, the ID of the subject was included as a random effect, and education level and marital status were added as control variables.
BAI, Beck Anxiety Inventory; BDI, Beck Depression Inventory.